Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. Results of a prospective randomized trial

Peritoneal Dialysis International

Volumn 34, Issue 3, 2014, Pages 271-277

  Nunez Moral M ^a   Sanchez Alvarez E ^a   Gonzalez Diaz I ^a   Pelaez Requejo B ^a   Fernandez Vina A ^a   Quintana Fernandez A ^a   Rodriguez Suarez C ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Exit site infection; Peritoneal dialysis; Polyhexanide

Indexed keywords

POLYHEXANIDE; POLYMER; UNCLASSIFIED DRUG; BIGUANIDE DERIVATIVE; POLY(HEXAMETHYLENEBIGUANIDE);

ADULT; APPLICATION SITE INFECTION; ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM JEIKEIUM; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OPEN STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; TRANSPLANTATION; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; INDWELLING CATHETER; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME;

BIGUANIDES; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

EID: 84917684754     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2012.00109     Document Type: Article

References (26)

1. Montenegro J. Prevention and treatment of peritoneal catheter exit-site infection. Nefrologia 1999; 19:502-7.
2. Castro Notario MJ. Chapter 34. In: Manual práctico de diálisis peritoneal. Badalona, Spain: SEN-SEDEN; January 2005:293-7
3. Vijt D, Castro MJ, EndallG, Lindley E, Elseviers M, EDTNA/ ERCA Research Board. Post insertion catheter care in peritoneal dialysis (PD) centres across Europe: results of the Post Insertion Project of the Research Board. EDTNA ERCA J 2004; 30:42-7.
4. Oltra-Rodriguez E. Efectividad clínica de los distintos abordajes del cuidado de salida del catéter de diálisis peritoneal. Institute Joanna Briggs, Institute de salud Carlos III, Consejería de salud y servicios sanitarios del Principado de Asturias. Enferm Clin 2006; 16:53-4.
5. Rao SP, Oreopoulos DG. Unusual complication of a polyurethane PD catheter. Perit Diallnt 1997; 17:440-1.
6. Piraino B, Bernasrdini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in gram-negative infection in peritoneal dialysis patients. Perit Dial Int 2003; 23:456-9.
7. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D'Agata EM. Mupirocin prophylaxis to prevent staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37:1629-38.
8. Riu S, Ruiz C, Martinez-Vea A, Peralta C, Oliver J. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effectof mupirocin ointment. Nephrol Dial Transplant 1998; 13:1870-1.
9. Annigeri R, Conly J, Vas S, Dedier H, Prakashan KP, Bargman JM, et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int 2001; 21: 554-9.
10. Teixidó J, Arias N, Tarrats L, Romero R. The microbial pattern of the catheter exit-site infection in peritoneal dialysis: A non-diphtheria Corynebacteria emergence? Nefrologia 2007; 27:350-8.
11. Minguela Pesquera JI, Ruiz de Gauna R, Muñoz Gonzalez RI. Complicaciones del túnelyorificiode salida del catéter peritoneal. In: Montenegro J, Correa-Rotter R, Riella MC. Tratado de Diálisis Peritoneal. Barcelona, Spain: Elsevier; 2009:259-72.
12. Carville K, Cuddigan J, Fletcher J, Fuchs J. Principios de las mejores prácticas: La infección de las heridas en la práctica clínica. Consenso internacional. London: MEP Ltd, 2008. www.mepltd.co.uk.
13. Kramer A, Daeschlein G, KammerlanderG, Andriessen A, Aspöck C, Bergemann R, et al. Consensus recommendation on wound antisepsis. Zeitschrift Wundheilung 2004; 3:110-20.
14. Martinez Cuervo F, López Moreno JS. Uso del Prontosan en el cuidado UPP. Ulcus clínica 2006; 4:6-9.
15. Martinez Cuervo F. La limpieza de la herida: paso imprescindible en el cuidado UPP. Ulcus clínica 2006; 3:6-11.
16. Grupo Nacionalpara elestudioyasesoramiento en úlceras por presión y heridas crónicas. Recomendaciones sobre la utilizadón de antisépticos en el cuidado de heridas crónicas. Documento VIII. December 2002. www.gneaupp.org.
17. Sansone G, Cirugeda A, Bajo MA, Del Peso G, Sanchez Tomero JA, Alegre L, et al. Clinical practice protocol update in peritoneal dialysis-2004. Nefrología 2004; 24:410-44.
18. Castro Notario MJ. Cuidados del orificio de salida del catéter peritoneal. In: Coronel F, Montenegro J, Selgas R, Celadilla O, Tejuca M. Manual práctico de Diálisis Peritoneal. Badalona, Spain: Ed Atrium Comunicación Estratégica; 2005: 293-7.
19. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, et al. International Society for Peritoneal Dialysis. Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 2010; 30:393-423.
20. De Miguel B, Arias Suárez N, Gascó Senet A, López Miravalles A, Ruiz Carbonell, M, Teixidó, J. Catéter peritoneal: valoración del orificio según criterios de Twardowski, modificados. Rev Soc Esp Enferm Nefrol 1997; lertrimestre:12-4.
21. Montenegro J, Saracho R, Aguirre R, Martínez I, Iribar I, Ocharán J. Exit-site care with ciprofloxacin otologic solution prevents polyurethane catheter infection in peritoneal dialysis patients. Perit Dial Int 2000; 20:209-14.
22. Abraham G, Savin E, Blake P, Dombros N, Símbolos K. Natural history of exit-site infection in patients on CAPD. Perit Dial Bull 1988;3:211-6.
23. Martin CM, Brier ME, Golper TA. Outcome of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int 1997; 52:524-9.
24. Koburger T, Hübner NO, Braun M, Siebert J, Kramer A. Standardized comparison of antiseptic efficacy of triclosan, PVP-iodine, octenidine dihydrochloride, polyhexanide and chlorhexidine digluconate. J Antimicrob Chemother 2010; 65:1712-9.
25. Sekiguchi J, Asagi T, Miyoshi-Akiyama T, Kasai A, Mizuguchi Y, Araake M, et al. Outbreak of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J Clin Microbiol 2007; 45:979-89.
26. Stel VS, van de Luijtgaarden MW, Wanner C, Jager KJ, on behalf of the European Renal Registry Investigators. The 2008 ERA-EDTA registry annual report-a precis. NDT plus 2011;4:1-13.